PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV

This adverse event was reported 7 times

These drugs are most commonly taken by patients reporting PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV:

# Drug Count
0 ADALIMUMAB 5
1 ADALIMUMAB-AATY 5
2 ADALIMUMAB-ADAZ 5
3 ADALIMUMAB-FKJP 5
4 URSODIOL 5
5 URSOSIOL 5
6 AZATHIOPRINE SODIUM 3
7 AZATHIOPRINE 2
8 FINGOLIMOD HCL 2
9 BISOPROLOL FUMARATE 1
See all common drugs associated with PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV

PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AZATHIOPRINE SODIUM 3 0.0012
1 URSOSIOL 5 0.0003
2 URSODIOL 5 0.0002
3 OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE 1 0.0001
4 ADALIMUMAB-FKJP 5 0.0001
5 PROCHLORPERAZINE MALEATE 1 0.0001
6 ADALIMUMAB-AATY 5 0.0001
7 FESOTERODINE FUMARATE 1 0.0001
8 ADALIMUMAB-ADAZ 5 0.0001
9 STANDARDIZED SENNA CONCENTRATE 1 0.0001
See all drugs enriched for association with PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV

PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bile Acid [EPC] 5 0.0002
1 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
2 beta3-Adrenergic Agonist [EPC] 1 0.0000
3 Purine Antimetabolite [EPC] 2 0.0000
4 Central Nervous System Stimulant [EPC] 1 0.0000
5 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
6 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
7 Thiazide Diuretic [EPC] 1 0.0000
8 Osmotic Laxative [EPC] 1 0.0000
9 Benzodiazepine [EPC] 1 0.0000
See all drug classes enriched for association with PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV